Abbreviations & Acronyms BMI = body mass index CT = computed tomography EBL = estimated blood loss GAPP = Grading system for Adrenal Pheochromocytoma and Paraganglioma IVC = inferior vena cava MRI = magnetic resonance imaging NA = not available NS = not significant RCT = randomized controlled trial RPA = retroperitoneal approach TPA = transperitoneal approach Objectives: To evaluate operative and oncological outcomes of laparoscopic adrenalectomy through a transperitoneal approach and retroperitoneal approach for large (>5 cm in diameter) pheochromocytomas. Methods: We retrospectively compared the results of a transperitoneal approach with those of a retroperitoneal approach in 22 patients (mean age 57.5 years, range 38-76 years) with unilateral large pheochromocytomas (12 right, 10 left). The mean body mass index, operation time, pneumoperitoneum time, estimated blood loss, fluctuation in blood pressure and complication rate were compared between the two approaches. Results: The mean tumor diameter (range) was 7.0 cm (range 5.2-15.5 cm), and no significant differences were observed between the transperitoneal approach and retroperitoneal approach in any baseline clinical parameter. For right-sided procedures, significant differences were found for operation time (113 vs 85 min), pneumoperitoneum time (93 vs 64 min) and estimated blood loss (96 vs 23 mL; P < 0.05, transperitoneal approach and retroperitoneal approach, respectively). No open conversion or recurrence was reported, but one right transperitoneal approach case required blood transfusion. No difference in these parameters was noted on the left side. Conclusions: For right side procedures, the retroperitoneal approach is feasible, safer and faster than the transperitoneal approach for large pheochromocytomas. Early transection of the feeding artery is beneficial for managing the tumor and reducing the risk of bleeding.
Introduction
Surgical removal is the most effective treatment for pheochromocytoma, but the surgery for large pheochromocytomas, usually defined as >5 cm in diameter, is challenging. The TPA, which was first reported in 1995, has become the gold standard for laparoscopic adrenalectomy because of the familiarity of the intra-abdominal anatomy and the wide working space. 1 However, the RPA, which was also first reported in 1995, provides direct access to the adrenal tumor and avoids potential injury to the intra-abdominal organs. 2 Studies focusing on the superiority of one approach have been carried out with small adrenal tumors. Two RCTs have shown that the TPA and RPA were equally efficacious and safe for small adrenal tumors. 3, 4 Chai et al. reported that the RPA was superior to the TPA with respect to the operative time, EBL, postoperative pain, length of hospitalization and cost-effectiveness. 4 The RPA is usually indicated for tumors <7 cm in diameter because of the more restricted space in this approach; 5, 6 however, some experienced centers have operated on larger tumors using the RPA. 7, 8 These observations do not apply to the removal of pheochromocytomas, especially large pheochromocytomas, because removal of pheochromocytomas produces hemodynamic instability and difficulty in dissection, resulting in a longer operative time, and greater EBL and potential risk of local malignancy than for other types of adrenal tumors. Several reports have shown that laparoscopic removal of pheochromocytomas, including large tumors, can be completed safely with minimal operative morbidity through the TPA. [9] [10] [11] Despite the accumulated evidence showing the superiority of the RPA for non-pheochromocytoma, large adrenal tumors, the safety and efficacy of the RPA for large pheochromocytomas are very limited. 12 The aim of the present study was to compare the outcomes of the TPA and RPA for laparoscopic removal of large pheochromocytomas (>5 cm in diameter).
Methods
We retrospectively compared the results of laparoscopic adrenalectomy for large pheochromocytomas through the TPA or RPA carried out by a single surgeon (KS) from January 2008 to December 2017. This study was approved by our institutional review board (H29-234).
Confirmation of the clinical diagnosis of pheochromocytoma was obtained by estimating the catecholamine levels in the blood and urine of patients with or without clinical symptoms. Urine adrenaline or noradrenaline levels greater than threefold the upper limit of the normal range were considered diagnostic for pheochromocytoma, according to the Japan Endocrine Society criteria. Radiological imaging tests included ultrasonography and MRI, but enhanced CT was obtained before the diagnosis of pheochromocytoma. All patients received up to 12 mg (minimum: 6 mg) of a-receptor blockers 2-3 months before surgery. Initially, 1 mg/day was given for 7-14 days in a stepwise manner. We chose the RPA for patients with previous abdominal surgery or radiation therapy, or for tumors with an identifiable feeding artery.
Under general anesthesia, the patients were placed in the lateral decubitus position with the lesion side up. Carbon dioxide was insufflated to 10 mmHg. The RPA was started by making a 1.5-cm incision immediately under the tip of the 12th rib, and the retroperitoneum space was created by balloon dilation. Five-and 10-mm trocars were placed under the subcostal margin. A wide incision was made in the lateroconal fascia from immediately below the diaphragm downward to the iliac fossa. After a wide retroperitoneal space was created, a 5-mm space for the assistant was created medially. For right-sided procedures, the IVC and renal pedicle were identified, and the central adrenal vein was cut during the final step. For left-sided procedures, identifiable feeding arteries, which were often observed around renal pedicle and just above psoas muscle, were cut (Fig. 1f) , the renal pedicle was dissected, and the central adrenal vein was identified close to the renal artery and cut after placing Hem-o-lok clips (Teleflex, Wayne, PA, USA). The tumor was able to be moved and rotated after this step. In the plane between the posterior Gerota's fascia and the psoas muscle, the feeding arteries to the adrenal tumor were cut with a vessel-sealing system (Ligasure; Covidien, Dublin, Ireland), or if the arteries were clearly identified, Hem-o-lok clips were used before sectioning of the arteries. Then, the tumor was exposed by dissecting the coarse connective tissues between the peritoneum and the anterior Gerota's fascia. Adrenal vessels, except for the central adrenal vein, were cut using the vessel-sealing system.
For the TPA, a total of four ports (12, 10, 5 and 5 mm) were used. For right-sided procedures, an additional medial 5-mm port was placed as a liver retractor, and the IVC was identified and exposed as the main landmark. After the liver was lifted, the peritoneum was incised below the liver edge and laterally along the liver border, but this step was difficult because of the limited operating field; therefore, it was carried out after the tumor was mobilized. The dissection was started near the renal pedicle. If a space between the IVC and the tumor was created, feeding vessels were cut using the vessel-sealing system. Once the adrenal vein was identified and controlled, the remainder of the dissection was carried out by mobilizing the tumor. For left-sided procedures, the white line of Toldt was dissected starting from high along the spleen to the iliac fossa, and the descending colon was mobilized. The renal pedicle was exposed, and the left central adrenal vein was identified and controlled. The remaining dissection was carried out by mobilizing the tumor, with special care not to injure the pancreas. The pathological diagnosis was made using the GAPP score. 13 Each patient's background, tumor diameter, EBL, total operation time and pneumoperitoneum time, and any hypertensive crisis (systolic blood pressure >180 mmHg) and postoperative complications were recorded. Statistical analysis was carried out using an unpaired t-test to compare the TPA with the RPA, and to compare the right and left sides. JMP software (SAS, Tokyo, Japan) was used. A P-value of <0.05 was considered statistically significant.
Results
During the study period, we consulted with 46 pheochromocytoma patients, and a total of 22 patients, 11 men and 11 women, with a mean age of 57.5 years (range 38-76 years), were included in the present study. A total of 16 (73%) patients presented with a history of uncontrolled hypertension despite medication, two (9%) were diagnosed during diabetes evaluation and four (18%) were incidentally diagnosed without any symptoms. Two patients showed catecholamineinduced cardiomyopathy. The mean BMI, tumor diameter, operation time, pneumoperitoneum time and EBL were 23.2 (range 19-29), 7.0 cm (range 5.2-15.5 cm), 107 min (range 72-204 min), 86 min (range 50-170 min) and 52 mL (range 5-370 mL), respectively. Table 1 shows the demographic data categorized by surgical approach. Only one patient who underwent a right-sided TPA approach required blood transfusion because of the severe adhesions of the tumor to the liver edge and IVC, which was correctable using a Hemo-lok clip and soft-mode coagulation. No patient died during the operation. During both procedures, 50% of patients presented with hemodynamic instability with hypertensive systolic peaks >180 mmHg during the tumor mobilization, but no significant difference in prevalence and the dosage of sodium nitroprusside was observed between the TPA and RPA (Table 1) . Intraoperative hypertensive crises were treated with sodium nitroprusside. As a complication, two TPA patients presented prolonged postoperative paralytic ileus because the duodenum was clasped and mobilized to obtain a sufficiently large operative field. No incidence of capsular rupture or residual tumor occurred during dissection and extraction of the specimen. The median follow-up period for the entire group was 43.7 months (range 8-120 months). All patients' symptoms, including diabetes, resolved completely, except for four patients who continued to experience residual hypertension. No long-term complications or recurrence were noted. Figure 1 shows representative right and left pheochromocytomas (Fig. 1a,d ) in which feeding arteries were identified by enhanced CT (Fig. 1b,e) . These arteries were easily identified in the RPA (Fig. 1c,f) . Table 1 shows patient background, tumor diameter and operative parameters categorized by TPA (n = 12) or RPA (n = 10). No significant difference was found between the two approaches. Table 2 shows the parameters stratified by the laterality. No significant differences were observed between the two approaches on the left side, whereas the operative time, pneumoperitoneum time and EBL were significantly reduced for the RPA compared with those for the TPA in right-sided procedures (P < 0.05). The pathological diagnoses were three cases with low risk of metastatic potential (GAPP score 2: 3 cases) and 18 cases with intermediate risk (GAPP score 3: 5 cases, GAPP score 4: 7 cases, GAPP score 5: 6 cases). One case was diagnosed as high risk (GAPP score 7; presented in Fig. 1a-c) . None of the cases developed the recurrences during the follow-up period.
Discussion
This is the first study to compare the feasibility and safety of laparoscopic adrenalectomy between the TPA and RPA in patients with large pheochromocytomas. Because of the rarity of the tumor, the number of patients was small, but the present study included the largest number of large pheochromocytomas and presented a case with the largest reported diameter (15.5 cm) of pheochromocytoma removed laparoscopically (Fig. 1) . Overall, both approaches were safe and efficient (Table 1) . Compared with the TPA, the RPA for the right side has been shown to have great merits: (i) easy to identify the feeding arteries after excellent bleeding control and tumor shrinkage; and (ii) easy to manage adrenohepatic fusion, because this step was the last during the procedure and the tumor was able to move and rotate. The choice of laparoscopic access (TPA vs RPA) depends on patient factors, and the surgeon's experience and familiarity with the procedures. The results of the present study will help surgeons to select the best approach for the removal of large pheochromocytomas.
A RCT comparing the efficacy and safety between the TPA and RPA for small adrenal tumors showed that the RPA is superior to the TPA in terms of the operative time, EBL, postoperative pain, length of hospitalization and costeffectiveness. However, just 18% of those tumors were pheochromocytomas, and this type of tumor was a predictor of extended operation time, with an odds ratio of 5.06, indicating that pheochromocytoma is a unique disease that should be discussed separately from other adrenal tumors. 4 For pheochromocytomas, <6 cm in diameter, results comparing the TPA and RPA have been controversial. Two studies have shown equivalence in the surgical approaches. 14, 15 In other studies, the RPA has been shown to reduce the operative time, duration of hospitalization and postoperative pain. 16, 17 A retrospective study including 99 pheochromocytomas and comparing the TPA and RPA showed that the mean operative time (117 vs 84 min), blood loss (340 vs 200 mL), hospital stay (7.8 vs 4.8 days) and complication rate were all significantly greater in the TPA group, showing the superiority of the RPA for small pheochromocytomas. 18 Regarding large pheochromocytoma, Chung et al. reported that RPA was a safe and feasible approach, but there was no comparison with TPA. 12 An investigation into which approach is preferable for large pheochromocytoma has been warranted.
Laparoscopic removal of large pheochromocytomas is still challenging, but six reports showed the feasibility and safety of the laparoscopic approach. [9] [10] [11] [19] [20] [21] Kercher et al. reported laparoscopic resection of 81 pheochromocytomas, of which 18 lesions were >6 cm. For the TPA, no conversions, deaths or blood transfusions were reported, and no significant difference was found between large and small tumors, except in the operative time. These authors concluded that laparoscopic removal of large pheochromocytomas could be carried out safely, with short hospital stays and minimal operative morbidity. 9 Indupur et al. and Boylu et al. reached the same conclusion for the TPA for tumors >8 cm. 19 Except in cases of intraoperative hemodynamic instability, large pheochromocytomas can be removed by the TPA as safely as small ones.
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The operation time from these studies tended to be longer (approximately 150 min) than with our RPA (98 min; Table 1 ), indicating that using the TPA for large pheochromocytomas will require a longer time and increase blood loss. Use of the RPA for large pheochromocytomas has been reported recently. 19, 21 Wang et al. reported that the RPA is a safe and feasible procedure for large adrenal masses (>7 cm in diameter), including pheochromocytomas. 20 De Fourmestraux et al. reached the same conclusion for tumors >6 cm. 20 However, these reports indicate that the operative time and EBL are correlated with tumor diameter, suggesting that the indications of the RPA for large pheochromocytomas should be further investigated and stratified. The present results clearly show that use of the RPA is advantageous for rightsided, large pheochromocytomas (Table 2) .
Pheochromocytoma is hypervascular and often adheres to adjacent tissue, resulting in bleeding and increased operative time. The greatest advantage of the RPA over the TPA was the early transection of feeding arteries between the posterior Gerota's fascia and the psoas muscle, resulting in shrinkage of the tumor and excellent bleeding control. In our experience of 10 RPA cases, at least one feeding artery was identified (Fig. 1c,f) and transected during the early phase of the surgery. Especially for right-side tumors, adhesion to the liver prevents establishment of an operative field in the TPA, but this is not a major problem for the RPA, because dissection between the tumor and liver is the final step of the procedure. One TPA case required blood transfusion because of the severe adhesions of the tumor to the liver edge and IVC. In addition, because the right adrenal vein is usually located posterolaterally to the IVC, we can easily identify and transect it through the RPA. A limited operative field and lack of landmarks are often noted as drawbacks of the RPA. In our experience, sufficient working space can be obtained by wide dissection of the lateroconal fascia and medially pushing the peritoneum. Furthermore, large tumors per se are an excellent landmark, and we did not become disoriented during the RPA. In addition, the timing of cutting the main adrenal vein did not affect the surgical outcomes in left-sided tumors. Sufficient administration of preoperative a-blocker and enough hydration during operation and also early transection of main feeding arteries might prevent the hypotensive events after cutting the main adrenal vein. During a mean of 44 months of follow up, no recurrence was observed. However, all the pheochromocytomas, especially large ones, are considered to have malignant potential. 22 If an oncologically satisfactory removal cannot be achieved during a laparoscopic procedure, conversion to an open procedure should not be delayed. The largest adrenal tumor size removed transperitoneally was 14 cm, which on histological examination proved to be an adrenocortical carcinoma. 23 We removed a 15.5-cm tumor together with the peritoneum to avoid any residual tumor. Shen et al. suggested that although the risk of malignancy increases with increasing tumor size, laparoscopic removal of pheochromocytomas is safe regardless of the tumor size. 24 The main limitations of the present study were the non-randomized retrospective design and the small sample size. The low incidence of large pheochromocytomas hinders the ability to carry out randomized and prospective studies. Distinct differences between right-and left-side tumors, even in this small sample, and the single surgeon's experience with laparoscopic adrenalectomy overcome the limitations of the present study. CT was taken for 17 cases (77%) of our series before the diagnosis of pheochromocytoma and 3-D construction to detect feeding arteries was possible; however, enhanced CT is basically contraindicated if diagnosis of pheochromocytoma is made, showing that it is not possible to prepare vascular information preoperatively for all pheochromocytomas. Without this information, feeding arteries are able to be detected easily in a fine operative field, especially through RPA.
Laparoscopic removal of large adrenal tumors requires advanced surgical skills because of the risk of capsular rupture, localization of the tumor close to visceral organs and richness of surrounding vessels. The present study showed that laparoscopic adrenalectomy was feasible and safe for large pheochromocytomas. The diameter of 15.5 cm was the largest in the present series, but larger tumors are supposed to be resected through both approaches after further experiences. Especially on the right side, the RPA showed greater benefits than the TPA. Randomized controlled studies are required to verify our preliminary conclusions, including oncological outcomes.
